Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 4/2004

01-05-2004 | Notas Clínicas

Retinopatía asociada al cáncer: Fotofobia intensa en paciente con cáncer de mama metastásico

Authors: Isabel Blancas López-Barajas, José Manuel Cervera Grau, Diego Márquez Medina, Javier Ángel García García, María Isabel Sáez Medina, José Luis García Puche

Published in: Clinical and Translational Oncology | Issue 4/2004

Login to get access
Metadata
Title
Retinopatía asociada al cáncer: Fotofobia intensa en paciente con cáncer de mama metastásico
Authors
Isabel Blancas López-Barajas
José Manuel Cervera Grau
Diego Márquez Medina
Javier Ángel García García
María Isabel Sáez Medina
José Luis García Puche
Publication date
01-05-2004
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 4/2004
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/BF02711729

Other articles of this Issue 4/2004

Clinical and Translational Oncology 4/2004 Go to the issue

Revisiones

Oxicodona: neuvo opioide en España

Announcement

Noticias

Revisiones

Gene expression profiling in breast cancer: from molecular portraits to personalized medicine

Artículo Especial

Aspectos generales en la redacción de artículos científicos y consideraciones prácticas en el ámbito de la Oncología

Originales

Diseño de un programa de base de datos para el seguimiento de pacientes, aplicando el Real Decreto 1566/1998 sobre control de calidad en radioterapia

Editorial

Red Temática de Grupos: patología molecular de los tumores sólidos pediátricos
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits